OrthoPediatrics market cap is $1.1 b, and annual revenue was $37.30 m in FY 2016

OrthoPediatrics Gross profit (Q3, 2017)9.5 M

OrthoPediatrics Gross profit margin (Q3, 2017), %76.7%

OrthoPediatrics Net income (Q3, 2017)-1.5 M

OrthoPediatrics EBIT (Q3, 2017)-756 K

OrthoPediatrics Cash, 30-Sept-20172.2 M

OrthoPediatrics EV1.1 B

OrthoPediatrics revenue was $37.30 m in FY, 2016 which is a 20.3% year over year increase from the previous period.

USD | FY, 2014 | FY, 2015 | FY, 2016 |
---|---|---|---|

## Revenue | 23.7m | 31.0m | 37.3m |

| 31% | 20% | |

## Cost of goods sold | 7.1m | 9.4m | 10.9m |

## Gross profit | 16.6m | 21.6m | 26.4m |

| 70% | 70% | 71% |

## Sales and marketing expense | 12.2m | 15.0m | 16.7m |

## R&D expense | 1.7m | 1.8m | 2.2m |

## General and administrative expense | 9.9m | 11.4m | 11.6m |

## Operating expense total | 23.7m | 28.2m | 30.5m |

## EBIT | (7.1m) | (6.6m) | (6.1m) |

| (30%) | (21%) | (16%) |

## Interest expense | 2.5m | 1.2m | 1.5m |

## Net Income | (9.5m) | (7.9m) | (6.6m) |

USD | Q3, 2016 | Q3, 2017 |
---|---|---|

## Revenue | 10.1m | 12.4m |

## Cost of goods sold | 3.0m | 2.9m |

## Gross profit | 7.2m | 9.5m |

| 71% | 77% |

## Sales and marketing expense | 4.3m | 5.6m |

## R&D expense | 501.0k | 1.1m |

## General and administrative expense | 2.9m | 3.5m |

## Operating expense total | 7.7m | 10.2m |

## EBIT | (523.0k) | (756.0k) |

| (5%) | (6%) |

## Interest expense | 399.0k | 761.0k |

## Net Income | (845.0k) | (1.5m) |

USD | FY, 2015 | FY, 2016 |
---|---|---|

## Cash | 3.9m | 1.6m |

## Accounts Receivable | 3.8m | 4.1m |

## Prepaid Expenses | 222.0k | 233.0k |

## Inventories | 11.7m | 14.0m |

## Current Assets | 22.5m | 20.8m |

## PP&E | 7.3m | 8.6m |

## Total Assets | 30.7m | 30.7m |

## Accounts Payable | 2.0m | 3.5m |

## Short-term debt | 101.0k | 107.0k |

## Current Liabilities | 6.3m | 7.3m |

## Long-term debt | 13.0m | 17.4m |

## Non-Current Liabilities | 13.0m | 17.4m |

## Total Debt | 13.1m | 17.5m |

## Total Liabilities | 19.4m | 24.7m |

## Common Stock | 1.0k | 1.0k |

## Additional Paid-in Capital | 17.4m | 12.8m |

## Retained Earnings | (71.6m) | (78.1m) |

## Total Equity | (54.1m) | (65.3m) |

## Debt to Equity Ratio | -0.2 x | -0.3 x |

## Debt to Assets Ratio | 0.4 x | 0.6 x |

## Financial Leverage | -0.6 x | -0.5 x |

USD | Q2, 2017 | Q3, 2017 |
---|---|---|

## Cash | 2.3m | 2.2m |

## Accounts Receivable | 6.5m | 5.7m |

## Prepaid Expenses | 960.0k | 615.0k |

## Inventories | 18.1m | 19.0m |

## Current Assets | 28.8m | 28.9m |

## PP&E | 9.8m | 9.7m |

## Total Assets | 40.0m | 41.1m |

## Accounts Payable | 6.1m | 5.1m |

## Short-term debt | 110.0k | 111.0k |

## Current Liabilities | 10.4m | 10.4m |

## Long-term debt | 25.4m | 27.5m |

## Non-Current Liabilities | 25.4m | 27.5m |

## Total Debt | 25.5m | 27.6m |

## Total Liabilities | 35.8m | 37.9m |

## Common Stock | 1.0k | 1.0k |

## Additional Paid-in Capital | 10.7m | 9.5m |

## Retained Earnings | (80.7m) | (82.2m) |

## Total Equity | (69.9m) | (72.5m) |

## Debt to Equity Ratio | -0.4 x | -0.4 x |

## Debt to Assets Ratio | 0.6 x | 0.7 x |

## Financial Leverage | -0.6 x | -0.6 x |

USD | FY, 2014 | FY, 2015 | FY, 2016 |
---|---|---|---|

## Net Income | (9.5m) | (7.9m) | (6.6m) |

## Depreciation and Amortization | 1.6m | 1.9m | 1.9m |

## Accounts Receivable | 375.0k | (1.0m) | (280.0k) |

## Inventories | (360.0k) | 1.6m | (1.0m) |

## Accounts Payable | (445.0k) | 1.4m | 1.5m |

## Cash From Operating Activities | (9.9m) | (892.0k) | (1.1m) |

## Purchases of PP&E | (3.1m) | (2.2m) | (4.3m) |

## Cash From Investing Activities | (3.3m) | (1.7m) | (4.8m) |

## Cash From Financing Activities | 19.7m | (98.0k) | 3.6m |

## Net Change in Cash | 6.5m | (2.7m) | (2.3m) |

## Interest Paid | 2.5m | 1.2m | 1.5m |

USD | Q2, 2016 | Q3, 2016 | Q2, 2017 | Q3, 2017 |
---|---|---|---|---|

## Net Income | (2.1m) | (2.9m) | (2.6m) | (4.1m) |

## Depreciation and Amortization | 903.0k | 1.4m | 1.1m | 1.7m |

## Accounts Receivable | (695.0k) | (74.0k) | (2.4m) | (1.6m) |

## Inventories | (2.8m) | (3.6m) | ||

## Accounts Payable | 1.9m | 1.8m | 2.6m | 1.6m |

## Cash From Operating Activities | (2.3m) | (2.4m) | (4.2m) | (3.9m) |

## Purchases of PP&E | (1.8m) | (2.6m) | (2.8m) | (3.9m) |

## Cash From Investing Activities | (1.8m) | (3.0m) | (3.1m) | (5.3m) |

## Cash From Financing Activities | 1.4m | 2.9m | 8.0m | 9.8m |

## Net Change in Cash | (2.7m) | (2.6m) | 697.0k | 629.0k |

## Interest Paid | 657.0k | 1.1m | 1.1m | 1.9m |

USD | FY, 2014 |
---|